PAMELA CROMER: Open Payments
NPI 1851366058 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 7 payments from 6 companies in 2025. Trend: 2023 $846 · 2024 $718 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $208 |
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| SANOFI-AVENTIS U.S. LLC | 1 | $43 |
Products named: REXULTI, SPRAVATO, CAPLYTA, KISUNLA, ZEPBOUND, TZIELD.
Industry payments across SC — which companies pay providers there.
